We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Pediatric Forum |

Cost Estimates of Prophylaxis—Reply

Timothy P. Stevens, MD
Arch Pediatr Adolesc Med. 2001;155(2):199. doi:10.1001/archpedi.155.2.199.
Text Size: A A A
Published online


In reply

The letter from Dr Moler identifies a common issue in interpreting cost-effectiveness analyses, namely, the assumptions used in the calculations. One goal in performing our cost-effectiveness analysis was to avoid assumptions that would overestimate the true cost of RSV prophylaxis with palivizumab. In the Impact trial, infants at 35 weeks' gestation or less and aged 6 months or younger were enrolled in the study with infants aged 24 months or younger with ongoing treatment for bronchopulmonary dysplasia. These enrollment criteria resulted in a mean age and weight of approximately 6 months and 4.9 kg, respectively. In our analysis we included only infants at 32 weeks' gestation or less and assumed prophylaxis for infants younger than 1 year. Excluding infants at 32 to 35 weeks' gestation (many of whom would be heavier at age 6 months than would infants at <32 weeks' gestation) and infants older than 1 year would lower the mean weight of our cohort and make 3.5 kg a more accurate assumption for our population. Dr Moler's point that weight assumption can greatly affect a drug cost analysis is a valid one. The importance of weight assumption can be emphasized using a sensitivity analysis (Figure 1). The range of $24 695 to $89 119 per hospitalization prevented dramatically underscores Dr Moler's point.

Figures in this Article


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption

Estimated incremental cost per hospitalization prevented using weight assumptions ranging from 2.5 to 7.5 kg, drug acquisition costs of $1056 per 100-mg vial, doses of 15 mg/kg, and drug efficacy of a 55% overall reduction in hospitalization.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.